Page last updated: 2024-12-07

soyasaponin bb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Soya saponins are a class of triterpenoid glycosides found in soybeans. Soya saponins have a variety of biological activities, including anti-inflammatory, anti-cancer, and cholesterol-lowering effects. Soya saponins are also known to have hypoglycemic effects, as well as reduce body weight and fat. Soya saponins can be extracted from soybean meal or soy protein isolate using different techniques, including solvent extraction and supercritical fluid extraction. The mechanism of action of soya saponins is complex and not fully understood. However, it is believed that they work by modulating the activity of various enzymes and receptors in the body. Soyasaponin bb is a specific type of soya saponin that has been shown to have several beneficial effects on human health. For example, studies have shown that soyasaponin bb can help to lower blood pressure, reduce cholesterol levels, and improve insulin sensitivity. Soya saponins have been shown to have anti-proliferative and pro-apoptotic effects in a variety of cancer cell lines. Soya saponins can bind to cholesterol in the gut, which then prevents its absorption into the bloodstream. In addition, they may also modulate the activity of certain enzymes involved in cholesterol synthesis. These effects can lead to a reduction in serum cholesterol levels. Due to these potential health benefits, soyasaponin bb is a promising candidate for the development of new drugs for the treatment of various diseases.'
```

soyasaponin Bb: has activity against polycystic kidney disease; isolated from soybean; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

soyasaponin I : A triterpenoid saponin that is composed of soyasapogenol B having an alpha-L-rhamnopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid moiety attached at the 3-position via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID122097
CHEMBL ID511016
CHEBI ID9211
SCHEMBL ID397064
MeSH IDM000611859

Synonyms (32)

Synonym
oleanane, b-d-glucopyranosiduronic acid deriv.
soyasaponin bb
soybean saponin fraction b1
scm 3b
b-d-glucopyranosiduronic acid, (3b,4b,22b)-22,23-dihydroxyolean-12-en-3-yl o-6-deoxy-.alpha.-l-mannopyranosyl-(1.2)-o-.beta.-d-galactopyranosyl-(1.2)-
soyasaponin i
51330-27-9
C08983
ccris 6617
beta-d-glucopyranosiduronic acid, (3beta,4beta,22beta)-22,23-dihydroxyolean-12-en-3-yl o-6-deoxy-alpha-l-mannopyranosyl-(1-2)-o-beta-d-galactopyranosyl-(1-2)-
CHEMBL511016
chebi:9211 ,
(2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8ar,9r,12as,14ar,14br)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,
5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]oxane-2-carboxylic ac
soyasaponin 1
(3beta,22beta)-22,24-dihydroxyolean-12-en-3-yl alpha-l-rhamnopyranosyl-(1->2)-beta-d-galactopyranosyl-(1->2)-beta-d-glucopyranosiduronic acid
(3beta,22beta)-22,24-dihydroxyolean-12-en-3-yl 6-deoxy-alpha-l-mannopyranosyl-(1->2)-beta-d-galactopyranosyl-(1->2)-beta-d-glucopyranosiduronic acid
SCHEMBL397064
AC-34174
Q-100575
soyasaponin-bb
AKOS030530134
PTDAHAWQAGSZDD-IOVCITQVSA-N
Q27108314
HY-N0310
CS-0008808
soyasaponin bb(soyasaponin i)
MS-31761
soyasaponinbb
O0587
DTXSID901031429
mfcd02752366

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The method was applied to a pharmacokinetic study of Abrus cantoniensis Hance in rats."( Simultaneous determination of abrine, hypaphorine, schaftoside and soyasaponin Bb in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study after oral administration of Abrus cantoniensis Hance extract.
Bu, Q; Huang, B; Li, C; Liu, C; Lu, P; Zhang, C, 2023
)
1.15

Bioavailability

ExcerptReferenceRelevance
"A human study was conducted to evaluate soyasaponin bioavailability in humans."( Soyasaponin I and sapongenol B have limited absorption by Caco-2 intestinal cells and limited bioavailability in women.
Hendrich, S; Hu, J; Murphy, PA; Reddy, MB, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
sialyltransferase inhibitorAn EC 2.4.99.* (glycosyltransferases transferring other glycosyl groups) inhibitor that interferes with the action of a sialyltransferase.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
pentacyclic triterpenoid
triterpenoid saponinA terpene glycoside in which the terpene moiety is a triterpenoid.
trisaccharide derivativeAn oligosaccharide derivative that is formally obtained from a trisaccharide.
carbohydrate acid derivativeA carbohydrate derivative that is formally obtained from a carbohydrate acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1744189Inhibition of rat alpha-2,3-O-ST3GALI assessed as reduction in sialylated-product formation at 1 mM using p-nitrophenyl T-antigen and CMP-NeuSAc incubated for 15 mins by reverse-phase HPLC analysis relative to control2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
AID1744187Inhibition of human alpha-2,6-ST6GAL1 assessed as reduction in sialylated-product formation at 100 uM using Gal-beta1-4GlcNac and CMP-NeuSAc incubated for 15 mins by reverse-phase HPLC analysis relative to control2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
AID589614Inhibition of iNOS activity in LPS-stimulated mouse RAW264.7 cells assessed as conversion of L-[14H] arginine to L-[3H] citruline per mg of protein after 24 hrs2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589627Inhibition of LPS-induced NF-kappaB activation in mouse RAW264.7 cells expressing pNF-kappaB-LUC at 25 to 200 ug/ml after 24 hrs by luciferase reporter gene assay relative to unstimulated cells2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589530Cytotoxicity against mouse RAW264.7 cells at 25 to 200 ug/ml after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID1354471Agonist activity at PPARalpha (unknown origin) expressed in human HepG2 cells cotransfected with PPRE X3-tk at 25 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2018Journal of natural products, 05-25, Volume: 81, Issue:5
Bioactivity-Guided Isolation of Potential Antidiabetic and Antihyperlipidemic Compounds from Trigonella stellata.
AID589622Inhibition of iNOS mRNA expression in LPS-stimulated mouse RAW264.7 cells at 100 ug/ml after 24 hrs by real time fluorescent quantitative real time PCR relative to negative control2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589616Inhibition of iNOS activity in LPS-stimulated mouse RAW264.7 cells assessed as conversion of L-[14H] arginine to L-[3H] citruline per mg of protein at 200 ug/ml after 24 hrs2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589619Inhibition of iNOS activity in LPS-stimulated mouse RAW264.7 cells assessed as conversion of L-[14H] arginine to L-[3H] citruline per mg of protein at 25 ug/ml after 24 hrs2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589623Inhibition of iNOS mRNA expression in LPS-stimulated mouse RAW264.7 cells at 200 ug/ml after 24 hrs by real time fluorescent quantitative real time PCR relative to negative control2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589618Inhibition of iNOS activity in LPS-stimulated mouse RAW264.7 cells assessed as conversion of L-[14H] arginine to L-[3H] citruline per mg of protein at 50 ug/ml after 24 hrs2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID1354473Agonist activity at PPARgamma (unknown origin) expressed in human HepG2 cells cotransfected with PPREaP2-tk at 50 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2018Journal of natural products, 05-25, Volume: 81, Issue:5
Bioactivity-Guided Isolation of Potential Antidiabetic and Antihyperlipidemic Compounds from Trigonella stellata.
AID359661Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered twice weekly after 1 week of initiation measured after 20 weeks by two stage carcinogenesis test1992Journal of natural products, Dec, Volume: 55, Issue:12
Anti-tumor-promoting activities of afromosin and soyasaponin I isolated from Wistaria brachybotrys.
AID589626Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-1 release by ELISA2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589621Inhibition of iNOS mRNA expression in LPS-stimulated mouse RAW264.7 cells at 50 ug/ml after 24 hrs by real time fluorescent quantitative real time PCR relative to negative control2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID1354472Agonist activity at PPARalpha (unknown origin) expressed in human HepG2 cells cotransfected with PPRE X3-tk at 12.5 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2018Journal of natural products, 05-25, Volume: 81, Issue:5
Bioactivity-Guided Isolation of Potential Antidiabetic and Antihyperlipidemic Compounds from Trigonella stellata.
AID589624Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha release by ELISA2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589625Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 release by ELISA2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID1744185Inhibition of rat alpha-2,3-N-ST3GALIII assessed as reduction in sialylated-product formation using Gal-beta1-4Glc and CMP-NeuSAc incubated for 1.5 hrs by reverse-phase HPLC analysis2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
AID589620Inhibition of iNOS mRNA expression in LPS-stimulated mouse RAW264.7 cells at 25 ug/ml after 24 hrs by real time fluorescent quantitative real time PCR relative to negative control2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID589617Inhibition of iNOS activity in LPS-stimulated mouse RAW264.7 cells assessed as conversion of L-[14H] arginine to L-[3H] citruline per mg of protein at 100 ug/ml after 24 hrs2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
AID1354475Agonist activity at PPARgamma (unknown origin) expressed in human HepG2 cells cotransfected with PPREaP2-tk at 12.5 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2018Journal of natural products, 05-25, Volume: 81, Issue:5
Bioactivity-Guided Isolation of Potential Antidiabetic and Antihyperlipidemic Compounds from Trigonella stellata.
AID1354470Agonist activity at PPARalpha (unknown origin) expressed in human HepG2 cells cotransfected with PPRE X3-tk at 50 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2018Journal of natural products, 05-25, Volume: 81, Issue:5
Bioactivity-Guided Isolation of Potential Antidiabetic and Antihyperlipidemic Compounds from Trigonella stellata.
AID1354474Agonist activity at PPARgamma (unknown origin) expressed in human HepG2 cells cotransfected with PPREaP2-tk at 25 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2018Journal of natural products, 05-25, Volume: 81, Issue:5
Bioactivity-Guided Isolation of Potential Antidiabetic and Antihyperlipidemic Compounds from Trigonella stellata.
AID1744188Inhibition of rat alpha-2,3-O-ST3GALI assessed as reduction in sialylated-product formation at 500 uM using p-nitrophenyl T-antigen and CMP-NeuSAc incubated for 15 mins by reverse-phase HPLC analysis relative to control2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis.
AID589528Inhibition of iNOS-mediated nitric oxide production in LPS-stimulated mouse RAW264.7 cells measured after 24 hrs by Griess reaction method2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.56)18.7374
1990's11 (17.19)18.2507
2000's20 (31.25)29.6817
2010's25 (39.06)24.3611
2020's7 (10.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.73 (24.57)
Research Supply Index4.20 (2.92)
Research Growth Index5.64 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.54%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (98.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]